Product Information
LEVETIRACETAM 250 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0599 per EA under NDC 68001040207. Its NADAC has been published 333 times since Feb 12, 2020.
Strength
250 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001040207
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA078993On Market Since
6/19/2019
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 250 MG TABLET has been published 333 times since Feb 12, 2020, and over the history we have for it it has declined 29.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0599 per EA |
|---|---|
| All-time high | $0.0915 (Aug 11, 2021) |
| All-time low | $0.0454 (Nov 20, 2024) |
| 52-week high | $0.0638 |
| 52-week low | $0.0562 |
| Median price | $0.0680 |
| Average price | $0.0706 |
| Largest weekly change | +30.7% (Aug 21, 2024) |
| Weeks tracked | 333 |
| Tracking since | Feb 12, 2020 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 250 MG TABLET, manufactured by BluePoint Laboratories, is $0.0599 per EA (NDC 68001040207), effective Jun 24, 2026.
How has the price of LEVETIRACETAM 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 250 MG TABLET has declined 29.7%. It has been tracked across 333 weekly CMS publications since Feb 12, 2020.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 250 MG TABLET?
Since Feb 12, 2020, the NADAC for LEVETIRACETAM 250 MG TABLET has ranged from a low of $0.0454 (Nov 20, 2024) to a high of $0.0915 (Aug 11, 2021), with a median of $0.0680 per EA.
Are there cheaper alternatives to LEVETIRACETAM 250 MG TABLET?
Yes. 17 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVETIRACETAM 250 MG TABLET, is $0.0494 per EA — about 18% below LEVETIRACETAM 250 MG TABLET.
Who manufactures LEVETIRACETAM 250 MG TABLET?
LEVETIRACETAM 250 MG TABLET (NDC 68001040207) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification